Artal Group’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-400,000	Closed	-$1.95M	–	140
2022 Q4	$1.95M	Hold	400,000	–	–	0.11%	86
2022 Q3	$5.77M	Hold	400,000	–	–	0.25%	51
2022 Q2	$6.05M	Hold	400,000	–	–	0.32%	47
2022 Q1	$4.75M	Hold	400,000	–	–	0.2%	80
2021 Q4	$6.48M	Hold	400,000	–	–	0.18%	82
2021 Q3	$11.4M	Hold	400,000	–	–	0.26%	69
2021 Q2	$13.5M	Hold	400,000	–	–	0.27%	71
2021 Q1	$12.1M	Buy	400,000 +114,972	+40%	+$3.48M	0.21%	80
2020 Q4	$14.1M	Hold	285,028	–	–	0.3%	70
2020 Q3	$10.9M	Sell	285,028 -15,002	-5%	-$576K	0.27%	63
2020 Q2	$13M	Sell	300,030 -99,970	-25%	-$4.32M	0.36%	49
2020 Q1	$10.4M	Hold	400,000	–	–	0.44%	39
2019 Q4	$12.5M	Hold	400,000	–	–	0.48%	36
2019 Q3	$10.4M	Hold	400,000	–	–	0.42%	37
2019 Q2	$9.15M	Buy	+400,000	New	+$9.15M	0.37%	46
2019 Q1	–	Sell	-50,000	Closed	-$1.02M	–	107
2018 Q4	$1.02M	Sell	50,000 -100,000	-67%	-$2.03M	0.04%	77
2018 Q3	$3.98M	Buy	+150,000	New	+$3.98M	0.1%	62